RMD vs SRRK · P/E 29, rev $5.65B vs $3.42B cap
ResMed Inc (RMD) versus Scholar Rock Holding Corp (SRRK) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Scholar Rock Holding Corp (SRRK) is a biotechnology company listed on US.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported SRRK revenue for 2026-06-30 was $0. Net income was -$215.4M. SRRK currently screens at market cap $3.42B.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. SRRK currently screens at market cap $3.42B.
Not investment advice. Open the RMD and SRRK stock pages for the full models.
Not investment advice.